Nano-X Imaging Ltd. (NASDAQ:NNOX) is a medical device company that utilizes artificial intelligence (AI) to revolutionize diagnostic imaging, reflecting broader trends in the medical imaging industry. The company's journey includes navigating challenges of technological innovation and market
In a significant stride for medical imaging technology, Avicenna.AI, a company specializing in artificial intelligence for imaging, has secured 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its CINA-CSpine tool. This advanced AI tool is designed to assist in detecting and
Aidoc, a leading company in healthcare artificial intelligence (AI), recently achieved a significant milestone by receiving CE approvals for four new AI algorithms specifically designed for computed tomography (CT) image analysis in Europe. These state-of-the-art algorithms, which target serious
Avita Galion Hospital has embarked on a significant transformation in its diagnostic imaging services by becoming the first medical facility in Ohio to introduce the Fujifilm Magnetic Resonance Imaging (MRI) System, ECHELON Synergy. This system is powered by Deep Learning Reconstruction (DLR)
Artificial intelligence (AI) continues to make significant strides in various industries, and its integration into healthcare is particularly promising. However, a recent study by Osaka Metropolitan University evaluated the diagnostic abilities of generative AI models, specifically ChatGPT, in
The FDA has recently cleared a breakthrough in cardiac diagnostic technology: AISAP Cardio's AI-powered point-of-care ultrasound (POCUS) software platform. Developed by the Israeli healthcare technology company AISAP, this new software is specifically designed to diagnose structural heart diseases
